SCHEMBL25680719

SCHEMBL25680719

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5cccc6ccccc56)c4)nc(-c4ccc5cc(-c6ccccc6)ccc5c4)n3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
MAPT P10636 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
KDM4E B2RXH2 2/20 0.48
TP53 P04637 2/20 0.48
HSD17B10 Q99714 2/20 0.48
HPGD P15428 2/20 0.48
TSHR P16473 1/20 0.48
NFKB1 P19838 1/20 0.48
MAPK1 P28482 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
ATM Q13315 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA9 Q16790 2/20 0.47
MCL1 Q07820 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26278885 1.00 ALDH1A1 (0.48) ALDH1A1MAPTSMN1; SMN2KDM4ETP53
SCHEMBL26278535 1.00 ALDH1A1 (0.48) ALDH1A1MAPTSMN1; SMN2KDM4ETP53
SCHEMBL27257038 1.00 ALDH1A1 (0.48) ALDH1A1MAPTSMN1; SMN2KDM4ETP53
SCHEMBL24770267 1.00 ALDH1A1 (0.48) ALDH1A1MAPTSMN1; SMN2KDM4ETP53
SCHEMBL27252447 1.00 ALDH1A1 (0.48) ALDH1A1MAPTSMN1; SMN2KDM4ETP53
SCHEMBL25471687 1.00 ALDH1A1 (0.48) ALDH1A1MAPTSMN1; SMN2KDM4ETP53
SCHEMBL25680771 0.98 ALDH1A1 (0.47) ALDH1A1MAPTSMN1; SMN2KDM4ETP53
SCHEMBL25680747 0.98 CA12 (0.49) ALDH1A1MAPTSMN1; SMN2KDM4ETP53
SCHEMBL24770252 0.98 CA12 (0.48) ALDH1A1MAPTSMN1; SMN2KDM4ETP53
SCHEMBL24770248 0.98 CA12 (0.48) ALDH1A1MAPTSMN1; SMN2KDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11690292-B2 Organic electronic element comprising a compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-27 US disclosed
US-11690292-B2 Organic electronic element comprising a compound for organic electronic element and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2023-06-27 US disclosed
US-20230129535-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-27 US disclosed
US-20230129535-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11690292-B2 Organic electronic element comprising a compound for organic electronic element and an electronic device thereof ESR1, EML4, ORAI2 ALDH1A1 601/4885MAPT 1268/4885SMN1; SMN2 2010/4885
US-20230129535-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING A COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF ESR1, EML4, ORAI2 ALDH1A1 601/4885MAPT 1268/4885SMN1; SMN2 2010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.